Search Results - "Loebinger, M.R."

The antimicrobial susceptibility of non-tuberculous mycobacteria by Cowman, S, Burns, K, Benson, S, Wilson, R, Loebinger, M.R

“…Summary Objectives Pulmonary non-tuberculous mycobacterial infection (NTM) is a challenging and increasingly prevalent infection. Antimicrobial resistance is…”
Get full text

WS03.4 The distinct airways mycobiome in adult cystic fibrosis and bronchiectasis by Felton, I.C, James, P, Benson, S, Schelenz, S, Moffatt, M, Loebinger, M.R, Simmonds, N.J, Cookson, W.O.C

Get full text

ePS02.8 Prevalence and clinical associations of fungal airway isolates in the UK adult cystic fibrosis population by Felton, I.C, Yazbeck, L, Gunn, E, Moffatt, M, Cookson, W.O, Loebinger, M.R, MacNeill, S.J, Bilton, D, Simmonds, N.J

“…Objectives To establish the prevalence and species diversity of fungal airway isolates in adults with cystic fibrosis (CF) from 2007 to 2012. To determine the…”
Get full text

WS1.6 Successful treatment of Mycobacterium abscessus infection in cystic fibrosis patients using a novel regimen by Jones, A.L, Perrin, F, Hurt, K, Cowman, S, Alshafi, K, Gyi, K, Loebinger, M.R, Simmonds, N.J, Bilton, D

Get full text

Aspergillus Serologic Findings and Clinical Outcomes in Patients With Bronchiectasis by Pollock, J., Goeminne, P.C., Aliberti, S., Polverino, E., Crichton, M.L., Ringshausen, F.C., Dhar, R., Vendrell, M., Burgel, P.R., Haworth, C.S., De Soyza, A., De Gracia, J., Bossios, A., Rademacher, J., Grünewaldt, A., McDonnell, M., Stolz, D., Sibila, O., van der Eerden, M., Kauppi, P., Hill, A.T., Wilson, R., Amorim, A., Munteanu, O., Menendez, R., Torres, A., Welte, T., Blasi, F., Boersma, W., Elborn, J.S., Shteinberg, M., Dimakou, K., Chalmers, James D., Loebinger, M.R.

Get full text

ePS3.08 Inhaled powder tobramycin (TIP): cyclical versus continuous treatment: iBEST Study by Alkhatib, A., Einarsson, G.G., Lee, A.J., O’Neill, K., Brown, V., Gilpin, D.F., Angyalosi, G., Malaterre, V., Loebinger, M.R., Chalmers, J.D., Blasi, F., Haworth, C.S., Elborn, J.S., Tunney, M.M.

Get full text

P147 Changes in Pseudomonas aeruginosa phenotypes following the development of tobramycin resistance by McCleave, R.P., Li, Z., Einarsson, G.G., Tunney, M.M., Loebinger, M.R., Chalmers, J.D., Elborn, S.J., Haworth, C.S., Sherrard, L.J.

Get full text

WS19-5 Bacterial and fungal microbiota associated with fungal disease in cystic fibrosis and bronchiectasis by Cuthbertson, L., Felton, I.C., James, P., Turek, E., Cox, M.J., Benson, S., Schelenz, S., Loebinger, M.R., Simmonds, N.J., Moffatt, M.F., Cookson, W.O.C.

Get full text

Thrombolysis in pulmonary embolism: are we under-using it? by Loebinger, M.R., Bradley, J.C.

Get full text

TACTICAL: A phase I/II trial to assess the safety and efficacy of MSCTRAIL in the treatment of metastatic lung adenocarcinoma by Davies, Alice, Sage, Beth, Kolluri, Krishna, Alrifai, Doraid, Graham, Rebecca, Weil, Ben, Rego, Rita, Bain, Owen, Patrick, P. Stephen, Champion, Kim, Day, Alex, Popova, Bilyana, Wheeler, Graham, Fullen, Dan, Kalbur, Tammy, Forster, Martin, Lowdell, Mark, Janes, Sam

“…Abstract only TPS9116 Background: Mesenchymal stromal cells (MSCs) migrate to and incorporate into tumour stroma allowing them to act as vehicles for…”
Get full text